Kedalion Therapeutics Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
Kedalion Therapeutics is a small biotechnology company based in Menlo Park, California, focused on ophthalmic drug development in the clinical stage. It uses a delivery approach for topical eye medications that enables precise dosing, achieving comparable efficacy with an 80% reduction in dose versus standard eye drops, and it aims to reduce side effects while improving patient comfort and convenience in self-administration. Its work centers on ophthalmic topical therapies for patients needing eye treatments. In 2022, Novartis Pharmaceuticals Corporation acquired Kedalion Therapeutics, integrating its delivery platform into Novartis' portfolio.